Rasio Nilai Pasar marang Nilai Buku Alnylam Inc. (ALNY)

Alnylam Inc. - logo grafis emiten ALNY

Alnylam Pharmaceuticals (ALNY) bases its environmental policy on chemical waste recycling and laboratory energy efficiency. The historical relationship between market cap and book value demonstrates management's ability to maintain a market premium, with the current level sitting around 22.76. Risks are linked to high R&D costs and competition within the orphan drug sector, yet the strategy of expanding the RNA platform into the cardiology market opens new growth prospects.

Kapitalisasi Pasar marang Aset Bersih Alnylam Corp (ALNY): kanggo periode 04.07.2022 - 29.10.2026
Barang unggulan Alnylam Pharmaceuticals, Inc.

To identify fundamental stability, investors must track the market-to-book ratio, calculated as the ratio of the total market capitalization to the value of net assets. This chart allows for an assessment of the company's premium, which is critical for Alnylam Pharmaceuticals (ALNY) given its reliance on a narrow drug portfolio and the risks associated with late-stage clinical trial failures.

Analisis pesaing

VRTX (Vertex Pharmaceuticals) - Rasio Kapitalisasi marang Aset Bersih|Koefisien Nilai Pasar marang Nilai Buku insmed.com (INSM)|Rasio Nilai Pasar marang Nilai Buku United Therapeutics Corporation|BioMarin Pharmaceutical Inc. (BMRN) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku BridgeBio Pharma Inc (BBIO)|BGM: Kapitalisasi Pasar marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku COGT (Cogent Biosciences)|xerispharma.com (XERS) - Koefisien Nilai Pasar marang Nilai Buku|Keros Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Arcturus Therapeutics Inc (ARCT) - Rasio Kapitalisasi marang Aset Bersih|ETON: Rasio Kapitalisasi Pasar marang Nilai Buku|KMDA - Kapitalisasi Pasar marang Nilai Buku|FULC (Fulcrum Therapeutics) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Abeona|Rasio Nilai Pasar marang Nilai Buku Mereo BioPharma (MREO)|Rasio Nilai Pasar marang Nilai Buku PLX (Protalix BioTherapeutics Inc.)|Rasio Kapitalisasi Pasar marang Nilai Buku PLRX (Pliant Therapeutics, Inc.)|Kapitalisasi Pasar marang Nilai Buku Applied Therapeutics Inc. (APLT)|RNTX: Rasio Kapitalisasi marang Aset Bersih|Kapitalisasi Pasar marang Aset Bersih GELS|AYTU: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Chemomab Therapeutics Ltd. (CMMB)|SRXH (SRx Health Solutions Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku PLRZ (Polyrizon Ltd.)|Rasio Kapitalisasi marang Aset Bersih AEZS (Aeterna Zentaris)|CYTH (cyclotherapeutics.com) - Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Inozyme Pharma INZY|RPHM (Reneo Pharmaceuticals Inc.) - Kapitalisasi Pasar marang Aset Bersih|Aeterna Zentaris - Rasio Kapitalisasi Pasar marang Nilai Buku